ArticleJSAMS plus2026
Chief medical officers' perceptions of athlete cardiac screening.
Article in JSAMS plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elite athletes are screened for conditions associated with sudden cardiac arrest or death. The complexities of the real-world implementation of cardiac screening are poorly understood. The aim of this study was to understand the barriers and enablers to best practice athlete cardiac screening programs in Australia and New Zealand. Methods: Semi-structed interviews were conducted with chief medical officers (CMOs) of elite sporting organisations in Australia and New Zealand and transcribed verbatim. Interview questions were focused on CMOs' perceptions of cardiac screening within their sporting organisation. Inductive thematic analysis was used to assign themes. Results: Twelve chief medical officers were interviewed between June 2023 and May 2024. Several themes were identified as barriers and enablers to best practice athlete cardiac screening. These themes were: 1. availability of sports cardiology expertise; 2. organisational investment in cardiac screening; 3. timing of screening; 4. accessibility of athletes; 5. athletes aged under 18; and 6. athlete engagement with cardiac screening. For CMOs, key enablers to best practice cardiac screening were access to sports cardiology expertise, together with organisational investment in the form of administrative assistance and sufficient funding to run cardiac screening. A key barrier was the organisational pressure on clinicians to make a clinical decision without sufficient clinical information, especially when screening occurred very close to competition. Conclusions: To implement best practice cardiac screening, there needs to be greater access to sports cardiology expertise, improvement in funding models, and policies guiding the timing of screening before competition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.